Works matching DE "HIV protease inhibitors"
Results: 455
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Planning and Evaluation of Bioequivalence Studies of Lopinavir/Ritonavir Preparations.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 53, n. 12, p. 1101, doi. 10.1007/s11094-020-02130-0
- By:
- Publication type:
- Article
Issues Related to Patent Protecton of Darunavir and its Analogs.
- Published in:
- Pharmaceutical Chemistry Journal, 2016, v. 50, n. 6, p. 413, doi. 10.1007/s11094-016-1461-7
- By:
- Publication type:
- Article
Conformational Polymorphism of Elsulfavirine Sodium Salt.
- Published in:
- Journal of Structural Chemistry, 2024, v. 65, n. 2, p. 412, doi. 10.1134/S0022476624020185
- By:
- Publication type:
- Article
Phlorotannins as HIV Vpu inhibitors, an in silico virtual screening study of marine natural products.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 4, p. 918, doi. 10.1002/bab.2014
- By:
- Publication type:
- Article
Vanillic acid as phospholipase A<sub>2</sub> and proteases inhibitor: In vitro and computational analyses.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 3, p. 486, doi. 10.1002/bab.1943
- By:
- Publication type:
- Article
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1645, doi. 10.1080/14756366.2021.1954919
- By:
- Publication type:
- Article
Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from Candida parapsilosis.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 914, doi. 10.1080/14756366.2021.1906664
- By:
- Publication type:
- Article
Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 629, doi. 10.1080/14756366.2020.1724994
- By:
- Publication type:
- Article
Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 1451, doi. 10.1080/14756366.2019.1636234
- By:
- Publication type:
- Article
Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2013, v. 28, n. 1, p. 78, doi. 10.3109/14756366.2011.633907
- By:
- Publication type:
- Article
The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2012, v. 27, n. 1, p. 160, doi. 10.3109/14756366.2011.627508
- By:
- Publication type:
- Article
Prediction of HIV-1 protease inhibitory activity of 4-hydroxy-5,6-dihydropyran-2-ones: QSAR study.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 2, p. 288, doi. 10.3109/14756366.2010.496364
- By:
- Publication type:
- Article
Epoxide Syntheses and Ring-Opening Reactions in Drug Development.
- Published in:
- Catalysts (2073-4344), 2020, v. 10, n. 10, p. 1117, doi. 10.3390/catal10101117
- By:
- Publication type:
- Article
Saquinavir: From HIV to COVID-19 and Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070944
- By:
- Publication type:
- Article
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 6, p. 954, doi. 10.3390/biom10060954
- By:
- Publication type:
- Article
The ongoing imperative for immune tolerance induction in inhibitor management.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 183, doi. 10.1111/hae.13670
- By:
- Publication type:
- Article
Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Saquinavir. Clinical pharmacology and efficacy.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Antiviral Therapy of COVID-19.
- Published in:
- Scripta Medica, 2020, v. 51, n. 3, p. 131, doi. 10.5937/scriptamed51-28336
- By:
- Publication type:
- Article
GLOBAL DYNAMICAL ANALYSIS OF HIV MODELS WITH TREATMENTS.
- Published in:
- International Journal of Bifurcation & Chaos in Applied Sciences & Engineering, 2012, v. 22, n. 9, p. -1, doi. 10.1142/S0218127412502276
- By:
- Publication type:
- Article
Cardiovascular risks in Asian HIV-infected patients receiving boostedprotease inhibitor-based antiretroviral treatment.
- Published in:
- Journal of Infection in Developing Countries, 2021, v. 15, n. 2, p. 289, doi. 10.3855/jidc.12864
- By:
- Publication type:
- Article
Antiviral Medications, Part 2: HIV Antiretroviral Therapy.
- Published in:
- MEDSURG Nursing, 2017, v. 26, n. 5, p. 327
- By:
- Publication type:
- Article
evolving challenges confronting adults living with HIV in three North African countries during the COVID-19 crisis: a survey-based study.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2022, v. 116, n. 5, p. 462, doi. 10.1093/trstmh/trab157
- By:
- Publication type:
- Article
ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brief communication: The extent and determinants of viral suppression among patients on protease inhibitor-based Anti-retro-viral therapy undergoing intensive adherence counselling in a public HIV care center in Uganda.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00661-0
- By:
- Publication type:
- Article
Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo.
- Published in:
- Acta Pharmacologica Sinica, 2013, v. 34, n. 10, p. 1349, doi. 10.1038/aps.2013.69
- By:
- Publication type:
- Article
Early ritonavir-induced maculopapular eruption.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility.
- Published in:
- Biochemical Journal, 2019, v. 476, n. 2, p. 375, doi. 10.1042/BCJ20180692
- By:
- Publication type:
- Article
Potentially highly effective drugs for COVID-19: Virtual screening and molecular docking study through PyRx-Vina Approach.
- Published in:
- Frontiers in Health Informatics, 2023, v. 12, p. 1, doi. 10.30699/fhi.v12i0.478
- By:
- Publication type:
- Article
INVESTIGATION OF ANTIVIRAL POTENCIES OF PHENOLIC COMPOUNDS AGAINST NS2B-NS3 ZIKV PROTEASE: THE CASE OF VERBASCUM GLABRATUM SUBSP. BOSNENSE.
- Published in:
- Genetics & Applications, 2023, p. 51
- By:
- Publication type:
- Article
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6618, doi. 10.3390/jcm12206618
- By:
- Publication type:
- Article
Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1131, doi. 10.3390/jcm9041131
- By:
- Publication type:
- Article
Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 2025, doi. 10.3390/biomedicines11072025
- By:
- Publication type:
- Article
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review.
- Published in:
- Biomedicines, 2021, v. 9, n. 11, p. 1620, doi. 10.3390/biomedicines9111620
- By:
- Publication type:
- Article
Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 1044, doi. 10.3390/biomedicines9081044
- By:
- Publication type:
- Article
Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 15, n. 2, p. 1314, doi. 10.3892/etm.2017.5526
- By:
- Publication type:
- Article
Inhibition of osteoblast differentiation by ritonavir.
- Published in:
- Biomedical Reports, 2018, v. 9, n. 6, p. 491, doi. 10.3892/br.2018.1154
- By:
- Publication type:
- Article
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.
- Published in:
- HIV Medicine, 2024, v. 25, n. 9, p. 1058, doi. 10.1111/hiv.13662
- By:
- Publication type:
- Article
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 895, doi. 10.1111/hiv.13273
- By:
- Publication type:
- Article
Bioactive phytocompound mulberroside C and endophytes of Morus alba as potential inhibitors of HIV‐1 replication: a mechanistic evaluation.
- Published in:
- HIV Medicine, 2021, v. 22, n. 8, p. 690, doi. 10.1111/hiv.13116
- By:
- Publication type:
- Article
Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice.
- Published in:
- HIV Medicine, 2021, v. 22, n. 6, p. 519, doi. 10.1111/hiv.13062
- By:
- Publication type:
- Article
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.
- Published in:
- HIV Medicine, 2021, v. 22, n. 1, p. 47, doi. 10.1111/hiv.12962
- By:
- Publication type:
- Article
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 21, doi. 10.1111/hiv.12388
- By:
- Publication type:
- Article